Today marks a meaningful milestone -- I am starting as a lab investigator @CompOncMSK and thoracic oncologist @MSK_DeptOfMed, focused on improving treatment through a deep understanding of cancer evolution. I'll soon be looking for fellow travelers on this mission. Stay tuned!.

RT @DrMarkAwad: Congratulations to Dr. Mark Kris @MSKCancerCenter for being named a Giant of Cancer Care for his many contributions to adva….

RT @aventura71: 1/ 🚨New paper on ecDNAs from our lab! . We reveal a strategy to engineer extrachromosomal DNA (ecDNA) amplifications in cel….

A beautiful story by @FaltasLab on mutational processes in urothelial cancers. Elegant demonstration of fitness benefit of CCND1 ecDNA during chemotherapy. We will learn a lot from WGS of clinical samples re interactions btw treatment and cancer genomes. Congrats to the authors!.

So glad that I was able to participate in this wonderful multi-year team effort! #SPECIFICancer @CancerGrand @TheMarkFdn.

So excited to be here with great people who will lead medicine and science! Thanks for @BWFUND for this opportunity. #CAMS #2024BWF

RT @MSKCancerCenter: 🗣️11 of MSK’s talented scientists & clinicians were selected to appear in an off-Broadway musical called “Lifeline." T….

Fusion variant-specific tumor suppressors in ALK+ lung cancers. SETD2 inactivation conferred a larger impact on tumorigenesis in the context of EML4-ALK v3 (fusing exon 6 of EML4 and exon 20 of ALK) than v1 (e13-e20).

@charlesrudin @natasharekhtman @SamTTweets @ChrisFebres An example of shattering three chromosomes and putting the pieces together to form 1) derivative chromosomes and 2) ecDNAs amplying oncogenes. Not a cherry-picked case, was rather a general pattern in these cases. Still surprising that this has happened early in their oncogenesis

Was lucky to join this team! A rare subgroup of SCLC originates from carcinoids. Surprisingly, their genomic hallmark was whole-chromosomal chromothripsis amplifying oncogenes. Thanks and congrats to my mentors and the leads @charlesrudin @natasharekhtman @SamTTweets @ChrisFebres.

Unexpected role of Fanconi anemia pathway in chromothripsis. It’s just incredible learning experience to follow the experimental papers since the initial description of chromothripsis in 2011. Amazing biology.

Wonderful opportunity to interact with the thought leaders of EGFR+ lung cancer. The inaugural meeting in 2019 motivated me to come back to clinic.

RT @PeterLyLab: We spent two days in the mountains discussing how cancer genomes become such a chaotic and rearranged mess. Thanks to the p….

RT @imartincorena: Peter Campbell leaves the Sanger Institute at the end of the year to become Quotient's CSO. A mentor and one of my favou….

Thanks so much to my career mentors and friends. You led & sustained me continue this journey! @peter_j_park @elledge_stephen @LeciaSequist @JamesClearyMD @isidrolauscher @dcgulhan Aaron Hata and David Pellman.

This would not have been possible without helping hands from my mentors, collaborators, and friends at MSK. Special thanks to @SohrabShah @charlesrudin @HelenaYu923 @marcjwills_ who inspire and drive me to move forward. Thanks to @MSK_DeptOfMed for unwavering support.

7 years ago, I made the bold decision to move to the US instead of becoming clinical faculty in my home country. Through an adventurous journey, I'm getting closer to my goal. Thrilled and honored to receive @BWFUND #CAMS, which will lay the foundation for my research program!.

Why ALK fuses w/ EML4 in lung cancers and not often w/ KIF5B? We never see TMPRSS2-ALK and what's the biology behind? An exciting paper from @chiarlelab led by translocation expert @TC_Cheong. A major step forward to understand the mechanisms of SVs!

Awesome opportunity to work with the rising star of this field in an exciting team!.

RT @ReiterLab: Please read, send feedback and retweet link to free full-text work on how a variant cell cycle coordinates differentiation o….